An important step in understanding whether heart failure affects men and women differently
is to define the clinical characteristics and patterns of treatment in women with
this disease (
1
,
2
). We reviewed the Study of Patients Intolerant of Converting Enzyme inhibitors (SPICE)
registry, a large registry of patients with left ventricular systolic dysfunction,
to describe the clinical features and trends in medication use in women. We also sought
to identify any differences between the sexes in the use of angiotensin-converting
enzyme (ACE) inhibitors, diuretics, and other heart-failure medications.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults.J Am Geriatr Soc. 1997; 45: 968-974
- Where are all the women with heart failure?.J Am Coll Cardiol. 1997; 30: 1417-1419
- Contemporary management of patients with left ventricular systolic dysfunction.Eur Heart J. 1999; 20: 1182-1190
Granger CB, Ertl G, Kuch J, et al. A randomized trial of candesartan cilexetil in patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. Am Heart J. 2000 139:4;609–17.
- National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure.Arch Intern Med. 1997; 157: 2460-2464
- Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy.Arch Intern Med. 1996; 156: 1669-1673
- Heart failure between 1986 and 1994; temporal trends in drug-prescribing practices.Am Heart J. 1997; 134: 901-909
- Prediction of creatinine clearance from serum creatinine.Nephron. 1976; 16: 31-41
- Tolerability of enalapril initiation by patients with left ventricular dysfunction.Am Heart J. 1994; 128: 358-364
- Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD).Am Heart J. 1996; 131: 350-355
- Studies of Left Ventricular Dysfunction (SOLVD) Registry.Am J Cardiol. 1992; 70: 347-353
- Clinical characteristics of patients in studies of left ventricular dysfunction (SOLVD).Am J Cardiol. 1992; 70: 894-900
- The epidemiology of heart failure.J Am Coll Cardiol. 1993; 22: 6A-13A
- Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.N Engl J Med. 1991; 325: 293-302
- Effects of enalapril on mortality in severe congestive heart failure.N Engl J Med. 1987; 316: 1429-1435
- Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial.N Engl J Med. 1992; 327: 669-677
Konstam M, Dracup K, Baker D. Heart Failure: Evaluation and Care of Patients with Left Ventricular Dysfunction. Clinical Practice Guideline No. 11. Rockville, MD: AHCPR, 1994.
- Clinical trials of diuretic therapy in heart failure.J Am Coll Cardiol. 1993; 22: 165A-171A
Article info
Publication history
Published online: August 16, 2004
Accepted:
June 21,
2000
Received in revised form:
June 21,
2000
Received:
April 3,
2000
Footnotes
☆Supported by a grant from AstraZeneca, Wayne, Pennsylvania, and Mölndal, Sweden.
Identification
Copyright
© 2000 Excerpta Medica Inc. Published by Elsevier Inc. All rights reserved.
